Earendil Labs raises $787M to power AI biotech, eyes a Hong Kong IPO
US-headquartered but China-rooted Earendil Labs says it has raised $787 million in private funding to fuel its AI-driven biotech platform and is reportedly considering a Hong Kong listing.